Drugs / BGE-117
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05152641 | Apr 2022 → Apr 2023 | anemia | BioAge Labs, Inc. | Withdrawn | No outcome recorded Stop: Enrollment |
| Phase 2 | NCT04815603 | Mar 2021 → Apr 2022 | anemia | BioAge Labs, Inc. | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BGE-117 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05152641 ↗ |
| Route | Oral | “taken by mouth” NCT04815603 ↗ |